Evidence map›Paper›PMID 37113727›Full record

ArticleEcancermedicalscience2023

Role of perigastric arcade removal in serous epithelial ovarian cancers.

Rohini Vinayak Kulkarni, Manoranjan Mohapatra, Bhagyalaxmi Nayak, Sagarika Samantaray, Janmejaya Mohapatra, Jita Parija, Sushil Kumar Giri

Open access · goldAbstract read
In one paragraph

Article in Ecancermedicalscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rohini Vinayak KulkarniDepartment of Gynaecological Oncology, Tata Memorial Centre, Mumbai 400012, India.
Manoranjan MohapatraDepartment of Gynecological Oncology, Acharya Harihar Post Graduate Institute of Cancer, Cuttack 753007, Odisha, India.
Bhagyalaxmi NayakDepartment of Gynecological Oncology, Acharya Harihar Post Graduate Institute of Cancer, Cuttack 753007, Odisha, India.
Sagarika SamantarayDepartment of Pathology, Acharya Harihar Post Graduate Institute of Cancer, Cuttack 753007, Odisha, India.
Janmejaya MohapatraDepartment of Gynecological Oncology, Acharya Harihar Post Graduate Institute of Cancer, Cuttack 753007, Odisha, India.
Jita ParijaDepartment of Gynecological Oncology, Acharya Harihar Post Graduate Institute of Cancer, Cuttack 753007, Odisha, India.
Sushil Kumar GiriDepartment of Gynecological Oncology, Acharya Harihar Post Graduate Institute of Cancer, Cuttack 753007, Odisha, India.
Institute of Cancer Research · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Omentectomy is an essential part of cytoreductive surgery (CRS). However, removal of perigastric arcade (PGA) of the omentum is a controversial aspect of omentectomy in view of the fear of injury, vascular compromise and gastroparesis. Hence, we conducted a study to evaluate the necessity and effect of removal of PGA during omentectomy. Methods: The nature of the study was a prospective observational study. The study period was for 1 year between 1.3.2019 and 29.2.2020. Patients with stage III to IV serous epithelial ovarian cancers - chemo naive/post neoadjuvant chemotherapy, without macroscopic involvement of the PGA were included in the study. Patients were divided into two groups - those who had PGA removed (group 1) and those whose PGA was preserved (group 2). Pre, intra and postoperative factors between the two groups were compared using standard statistical methods. Results: Micrometastasis to PGA was present in 36.4% of the patients in group 1. The predictors for this involvement included gross involvement and microscopic involvement of the mobile part of the omentum ( Conclusion: Micrometastasis to PGA was noted in significant number of cases. Its removal is also a safe procedure with minimal morbidity and good postoperative outcomes especially in cases with significant peritoneal carcinomatosis. Hence, it should be considered, provided we are achieving a complete cytoreduction otherwise.

Indexed as

micrometastasisomentectomyovarian cancerperigastric arcade

Identifiers

PMID37113727
PMCPMC10129396
OpenAlexW4324027617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.